These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36036932)

  • 1. Hospital and Neurodevelopmental Outcomes in Nano-Preterm Infants Receiving Invasive vs Noninvasive Ventilation at Birth.
    Shukla VV; Souder JP; Imbrock G; Hu M; Rahman AKMF; Travers CP; Ambalavanan N; Carlo WA; Lal CV
    JAMA Netw Open; 2022 Aug; 5(8):e2229105. PubMed ID: 36036932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary partial pressure of carbon dioxide for predicting rehospitalization in preterm infants under noninvasive respiratory support with severe bronchopulmonary dysplasia.
    Shin SH; Shin JS; Kim EK; Kim HS
    Pediatr Pulmonol; 2021 Dec; 56(12):3863-3869. PubMed ID: 34547833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.
    Isayama T; Lee SK; Yang J; Lee D; Daspal S; Dunn M; Shah PS;
    JAMA Pediatr; 2017 Mar; 171(3):271-279. PubMed ID: 28114678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.
    Härtel C; Herting E; Humberg A; Hanke K; Mehler K; Keller T; Mauer I; Frieauff E; Meyer S; Thome UH; Wieg C; Schmidtke S; Kribs A; Göpel W;
    JAMA Netw Open; 2022 Aug; 5(8):e2225810. PubMed ID: 35943742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia.
    Lewis TR; Kielt MJ; Walker VP; Levin JC; Guaman MC; Panitch HB; Nelin LD; Abman SH;
    JAMA Pediatr; 2022 Sep; 176(9):852-859. PubMed ID: 35913704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
    JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality after 36 weeks postmenstrual age of extremely preterm infants in neonatal care: The impact of growth impairment and bronchopulmonary dysplasia.
    Dassios T; Williams E; Hickey A; Bhat R; Greenough A
    Early Hum Dev; 2022 Aug; 171():105618. PubMed ID: 35759944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of Bronchopulmonary Dysplasia Among Very Preterm Infants in the United States.
    Jensen EA; Edwards EM; Greenberg LT; Soll RF; Ehret DEY; Horbar JD
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34078747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study.
    Thomas SR; Jain SK; Murthy P; Joseph CJ; Soraisham A; Tang S; Dosani A; Lodha A
    Am J Perinatol; 2024 May; 41(S 01):e2505-e2513. PubMed ID: 37399847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Changes in Early Respiratory Support Management on Respiratory Outcomes of Preterm Infants.
    Xie L; Luo X; Li B; Du L; Wang Z; Liu Y; Chen J; Duan S; Yan L; Gao W
    Respir Care; 2022 Oct; 67(10):1310-1319. PubMed ID: 35764345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, Severity Patterns and Risk Factors of Bronchopulmonary Dysplasia in Preterm Infants Younger than 32 Weeks of Gestation in a Tertiary Centre in Oman.
    Al Mandhari H; Khan A; Al Saadi A; AboAnza M; Rizvi SGA; Panchatcharam SM; Abdulatif M; Al Qassabi S; Quach S
    Sultan Qaboos Univ Med J; 2024 May; 24(2):259-267. PubMed ID: 38828256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
    Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.